Issued: 27 January 2021, London UK (embargo lifts: 12:00pm GMT)Product Transfer Agreement • January 22nd, 2021
Contract Type FiledJanuary 22nd, 2021GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine